Cancer Drug: Is It Worth The Expense

Cancer Drug: Is It Worth The Expense

Photo: Newsradio WTAX

For the first time in a decade, an experimental drug has extended the life of patients with advanced lung cancer who relapsed after standard chemotherapy. But the benefit in the study was so small — six extra weeks, on average — that it is raising fresh questions about the value of some costly new cancer medicines.

Eli Lilly and Company’s drug Cyramza was tested in more than 1,200 patients. It is sold now for stomach cancer and costs $6,000 per infusion.

The study was discussed Saturday at a cancer conference where doctors also reported progress with new drugs against relapsed ovarian cancer and chronic lymphocytic leukemia, the most common type of leukemia in adults.

Recent Headlines

in Entertainment

REVIEW: Veteran cast can’t save ‘The Martian’


It has all the earmarks of a blockbuster, but still can't shake the feeling of missed opportunity.

in Entertainment

WHAT’S ON: New on Netflix, Amazon & Hulu in October


Get your remotes ready for a binge-worthy weekend of new movies and TV shows.

in Music

Rolling Stones get their own Cuervo bottle


The tequila maker is paying tribute to the rockers and their 1972 North American tour.